Serum IGF1 and insulin levels in girls with normal and precocious puberty

European Journal of Endocrinology

Volumn 166, Issue 5, 2012, Pages 903-910

  Sørensen, Kaspar ^a   Aksglaede, Lise ^a   Petersen, Jørgen Holm ^b   Andersson, Anna Maria ^a   Juul, Anders ^a  

^a Mental Health Services CPH   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GONADORELIN AGONIST; INSULIN; PROCREN; SOMATOMEDIN C; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGE; ARTICLE; BONE AGE; BREAST DEVELOPMENT; CENTRAL PRECOCIOUS PUBERTY; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; DIET RESTRICTION; DUAL ENERGY X RAY ABSORPTIOMETRY; EXON; FEMALE; GENE; GENE DELETION; GENE DOSAGE; GENE LOCATION; GENETIC ASSOCIATION; GENOTYPE; GH RECEPTOR GENE; HUMAN; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PRECOCIOUS PUBERTY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SOMATOMEDIN C BLOOD LEVEL;

ABSORPTIOMETRY, PHOTON; ADOLESCENT; AGE DETERMINATION BY SKELETON; AGE FACTORS; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; HUMANS; INSULIN; INSULIN-LIKE GROWTH FACTOR I; PUBERTY; PUBERTY, PRECOCIOUS; YOUNG ADULT;

EID: 84862079239     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-12-0106     Document Type: Article

References (37)

1. Veldhuis JD, Roemmich JN, Richmond EJ & Bowers CY. Somatotropic and gonadotropic axes linkages in infancy, childhood, and the puberty-adult transition. Endocrine Reviews 2006 27 101-140. (doi:10.1210/er.2005-0006)
2. Anderson CA, Zhu G, Falchi M, van den Berg SM, Treloar SA, Spector TD, Martin NG, Boomsma DI, Visscher PM & Montgomery GW. A genome-wide linkage scan for age at menarche in three populations of European descent. Journal of Clinical Endocrinology and Metabolism 2008 93 3965-3970. (doi:10.1210/jc.2007- 2568)
3. Veldhuis JD, Roemmich JN, Richmond EJ, Rogol AD, Lovejoy JC, Sheffield-Moore M, Mauras N & Bowers CY. Endocrine control of body composition in infancy, childhood, and puberty. Endocrine Reviews 2005 26 114-146. (doi:10.1210/er.2003-0038)
4. Tam CS, de Zegher F, Garnett SP, Baur LA & Cowell CT. Opposing influences of prenatal and postnatal growth on the timing of menarche. Journal of Clinical Endocrinology and Metabolism 2006 91 4369-4373. (doi:10.1210/jc. 2006-0953)
5. Juul A, Scheike T, Nielsen CT, Krabbe S, Muller J & Skakkebaek NE. Serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 levels are increased in central precocious puberty: effects of two different treatment regimens with gonadotropin-releasing hormone agonists, without or in combination with an antiandrogen (cyproterone acetate). Journal of Clinical Endocrinology and Metabolism 1995 80 3059-3067. (doi:10.1210/jc.80.10.3059)
6. Hiney JK, Ojeda SR & Dees WL. Insulin-like growth factor I: a possible metabolic signal involved in the regulation of female puberty. Neuroendocrinology 1991 54 420-423. (doi:10.1159/000125924)
7. Divall SA, Williams TR, Carver SE, Koch L, Brüning JC, Kahn CR, Wondisford F,Radovick S&WolfeA.Divergent roles of growth factors in the GnRH regulation of puberty in mice. Journal of Clinical Investigation 2010 120 2900-2909. (doi:10.1172/JCI41069)
8. Hiney JK, Srivastava V, Nyberg CL, Ojeda SR & Dees WL. Insulinlike growth factor I of peripheral origin acts centrally to accelerate the initiation of female puberty. Endocrinology 1996 137 3717-3728. (doi:10.1210/en.137.9. 3717)
9. Miller BH & Gore AC. Alterations in hypothalamic insulin-like growth factor-I and its associations with gonadotropin releasing hormone neurones during reproductive development and ageing. Journal of Neuroendocrinology 2001 13 728-736. (doi:10.1046/j.1365-2826.2001.00686.x)
10. Hiney JK, Srivastava VK, Pine MD & Les DW. Insulin-like growth factor-I activates KiSS-1 gene expression in the brain of the prepubertal female rat. Endocrinology 2009 150 376-384. (doi:10.1210/en.2008-0954)
11. Frontini MG, Srinivasan SR & Berenson GS. Longitudinal changes in risk variables underlying metabolic Syndrome X from childhood to young adulthood in female subjects with a history of early menarche: the Bogalusa Heart Study. International Journal of Obesity and Related Metabolic Disorders 2003 27 1398-1404. (doi:10.1038/sj.ijo.0802422)
12. Sorensen K, Mouritsen A, Mogensen SS, Aksglaede L & Juul A. Insulin sensitivity and lipid profiles in girls with central precocious puberty before and during gonadal suppression. Journal of Clinical Endocrinology and Metabolism 2010 95 3736-3744. (doi:10.1210/jc.2010-0731)
13. Moller N & Jorgensen JO. Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects. Endocrine Reviews 2009 30 152-177. (doi:10.1210/er.2008-0027)
14. Moran A, Jacobs DR Jr, Steinberger J, Cohen P, Hong C-P, Prineas R & Sinaiko AR. Association between the insulin resistance of puberty and the insulin-like growth factor-I/growth hormone axis. Journal of Clinical Endocrinology and Metabolism 2002 87 4817-4820. (doi:10.1210/jc.2002-020517)
15. Sorensen K, Aksglaede L, Munch-Andersen T, Aachmann-Andersen NJ, Leffers H, Helge JW, Hilsted L & Juul A. Impact of the growth hormone receptor exon 3 deletion gene polymorphism on glucose metabolism, lipids, and insulin-like growth factor-I levels during puberty. Journal of Clinical Endocrinology and Metabolism 2009 94 2966-2969. (doi:10.1210/jc.2009-0313)
16. Hussain MA, Schmitz O, Mengel A, Glatz Y, Christiansen JS, Zapf J & Froesch ER. Comparison of the effects of growth hormone and insulin-like growth factor I on substrate oxidation and on insulin sensitivity in growth hormone-deficient humans. Journal of Clinical Investigation 1994 94 1126-1133. (doi:10.1172/JCI117427)
17. Mauras N & Haymond MW. Are the metabolic effects of GH and IGF-I separable? Growth Hormone & IGF Research 2005 15 19-27. (doi:10.1016/j.ghir. 2004.12.003)
18. Mauras N, Martinez V, Rini A & Guevara-Aguirre J. Recombinant human insulin-like growth factor I has significant anabolic effects in adults with growth hormone receptor deficiency: studies on protein, glucose, and lipid metabolism. Journal of Clinical Endocrinology and Metabolism 2000 85 3036-3042. (doi:10.1210/jc.85.9.3036)
19. Savage MO, Blum WF, Ranke MB, Postel-Vinay MC, Cotterill AM, Hall K, Chatelain PG, Preece MA & Rosenfeld RG. Clinical features and endocrine status in patients with growth hormone insensitivity (Laron syndrome). Journal of Clinical Endocrinology and Metabolism 1993 77 1465-1471. (doi:10.1210/jc.77. 6.1465)
20. Zhou Y, Xu BC, Maheshwari HG, He L, Reed M, Lozykowski M, Okada S, Cataldo L, Coschigamo K, Wagner TE, Baumann G & Kopchick JJ. A mammalian model for Laron syndrome produced by targeted disruption of the mouse growth hormone receptor/binding protein gene (the Laron mouse). PNAS 1997 94 13215-13220. (doi:10.1073/pnas.94.24.13215)
21. Dos SC, Essioux L, Teinturier C, Tauber M, Goffin V & Bougneres P. A common polymorphism of the growth hormone receptor is associated with increased responsiveness to growth hormone. Nature Genetics 2004 36 720-724. (doi:10.1038/ng1379)
22. Sorensen K, Aksglaede L, Petersen JH, Leffers H & Juul A. The exon 3 deleted growth hormone receptor gene is associated with small birth size and early pubertal onset in healthy boys. Journal of Clinical Endocrinology and Metabolism 2010 95 2819-2826. (doi:10.1210/jc.2009-2484)
23. Jensen RB, Vielwerth S, Larsen T, Greisen G, Leffers H & Juul A. The presence of the d3-growth hormone receptor polymorphism is negatively associated with fetal growth but positively associated with postnatal growth in healthy subjects. Journal of Clinical Endocrinology and Metabolism 2007 92 2758-2763. (doi:10.1210/jc.2007-0176)
24. Toyoshima MT, Castroneves LA, Costalonga EF, Mendonca BB, Arnhold IJ & Jorge AA. Exon 3-deleted genotype of growth hormone receptor (GHRd3) positively influences IGF-1 increase at generation test in children with idiopathic short stature. Clinical Endocrinology 2007 67 500-504. (doi:10.1111/j.1365-2265.2007.02915.x)
25. Aksglaede L, Sorensen K, Petersen JH, Skakkebaek NE & Juul A. Recent decline in age at breast development: the Copenhagen Puberty Study. Pediatrics 2009 123 e932-e939. (doi:10.1542/peds.2008-2491)
26. Marshall WA & Tanner JM. Variations in pattern of pubertal changes in girls. Archives of Disease in Childhood 1969 44 291-303. (doi:10.1136/adc.44. 235.291)
27. Pantel J, Machinis K, Sobrier ML, Duquesnoy P, Goossens M & AmselemS. Species-specific alternative splicemimicry at the growth hormone receptor locus revealed by the lineage of retroelements during primate evolution. Journal of Biological Chemistry 2000 275 18664-18669. (doi:10.1074/jbc.M001615200)
28. Kanety H, Karasik A, Pariente C & Kauschansky A. Insulin-like growth factor-I and IGF binding protein-3 remain high after GnRH analogue therapy in girls with central precocious puberty. Clinical Endocrinology 1996 45 7-12. (doi:10.1111/j.1365-2265.1996.tb02053.x)
29. Yakar S, Liu JL, Fernandez AM, Wu Y, Schally AV, Frystyk J, Chernausek SD, Mejia W & Le Roith D. Liver-specific igf-1 gene deletion leads to muscle insulin insensitivity. Diabetes 2001 50 1110-1118. (doi:10.2337/diabetes.50.5. 1110)
30. Kamp GA, Manasco PK, Barnes KM, Jones J, Rose SR, Hill SC & Cutler GB Jr. Low growth hormone levels are related to increased body mass index and do not reflect impaired growth in luteinizing hormone-releasing hormone agonist-treated children with precocious puberty. Journal of Clinical Endocrinology and Metabolism 1991 72 301-307. (doi:10.1210/jcem-72-2-301)
31. Toth MJ, Cooper BC, Pratley RE, Mari A, Matthews DE & Casson PR. Effect of ovarian suppression with gonadotropin-releasing hormone agonist on glucose disposal and insulin secretion. American Journal of Physiology. Endocrinology and Metabolism 2008 294 E1035-E1045. (doi:10.1152/ajpendo.00789. 2007)
32. Mansfield MJ, Rudlin CR, Crigler JF Jr, Karol KA, Crawford JD, Boepple PA & Crowley WF Jr. Changes in growth and serum growth hormone and plasma somatomedin-C levels during suppression of gonadal sex steroid secretion in girls with central precocious puberty. Journal of Clinical Endocrinology and Metabolism 1988 66 3-9. (doi:10.1210/jcem-66-1-3)
33. Coutant R, de Casson FB, Rouleau S, Douay O, Mathieu E, Gatelais F, Bouhours-Nouet N, Voinot C, Audran M & Limal JM. Divergent effect of endogenous and exogenous sex steroids on the insulin-like growth factor I response to growth hormone in short normal adolescents. Journal of Clinical Endocrinology and Metabolism 2004 89 6185-6192. (doi:10.1210/jc.2004-0814)
34. vander Sluis IM, BootAM,Krenning EP, Drop SL&deMuinckKeizer- Schrama SM. Longitudinal follow-up of bone density and body composition in children with precocious or early puberty before, during and after cessation ofGnRHagonist therapy. Journal of Clinical Endocrinology and Metabolism 2002 87 506-512. (doi:10.1210/jc.87.2.506)
35. Sorensen K, Andersson AM, Skakkebaek NE & Juul A. Serum sex hormone-binding globulin levels in healthy children and girls with precocious puberty before and during gonadotropin-releasing hormone agonist treatment. Journal of Clinical Endocrinology and Metabolism 2007 92 3189-3196. (doi:10.1210/jc.2007-0231)
36. Elks CE, Perry JR, Sulem P, Chasman DI, Franceschini N, He C, Lunetta KL, Visser JA, Byrne EM, Cousminer DL, Gudbjartsson DF, Esko T, Feenstra B,Hottenga JJ, KollerDL,Kutalik Z, Lin P,Mangino M, Marongiu M, McArdle PF, Smith AV, Stolk L, van Wingerden SH, Zhao JH,Albrecht E, Corre T, Ingelsson E,Hayward C, Magnusson PK, Smith EN, Ulivi S, Warrington NM, Zgaga L, Alavere H, Amin N, Aspelund T, Bandinelli S, Barroso I, Berenson GS, Bergmann S, Blackburn H, Boerwinkle E, Buring JE, Busonero F, Campbell H, Chanock SJ, ChenW, Cornelis MC, Couper D, Coviello AD, d'Adamo P, de Faire U, de Geus EJ, Deloukas P, Döring A, Smith GD, Easton DF, Eiriksdottir G, Emilsson V, Eriksson J, Ferrucci L, Folsom AR, Foroud T, Garcia M, Gasparini P, Geller F, Gieger C, GIANT Consortium, Gudnason V, Hall P, Hankinson SE, Ferreli L, Heath AC, Hernandez DG, Hofman A, Hu FB, Illig T, Järvelin MR, Johnson AD, Karasik D, Khaw KT, Kiel DP, Kilpeläinen TO, Kolcic I, Kraft P, Launer LJ, Laven JS, Li S, Liu J, Levy D, Martin NG, McArdle WL, Melbye M, Mooser V, Murray JC, Murray SS, Nalls MA, Navarro P, Nelis M, Ness AR, Northstone K, Oostra BA, Peacock M, Palmer LJ, Palotie A, Paré G, Parker AN, Pedersen NL, Peltonen L, Pennell CE, Pharoah P, Polasek O, Plump AS, Pouta A, Porcu E, Rafnar T, Rice JP, Ring SM, Rivadeneira F, Rudan I, Sala C, Salomaa V, Sanna S, Schlessinger D, Schork NJ, Schork NJ, Scuteri A, Segrè AV, Shuldiner AR, Soranzo N, Sovio U, Srinivasan SR, Strachan DP, Tammesoo ML, Tikkanen E, Toniolo D, Tsui K, Tryggvadottir L, Tyrer J,Uda M, vanDamRM,van Meurs JB,Vollenweider P,WaeberG, Wareham NJ, Waterworth DM, Weedon MN, Wichmann HE, Willemsen G, Wilson JF, Wright AF, Young L, Zhai G, Zhuang WV, Bierut LJ, Boomsma DI, Boyd HA, Crisponi L, Demerath EW, van Duijn CM, Econs MJ, Harris TB, Hunter DJ, Loos RJ, Metspalu A, Montgomery GW, Ridker PM, Spector TD, Streeten EA, Stefansson K, Thorsteinsdottir U, UitterlindenAG,Widen E,Murabito JM, Ong KK & Murray A. Thirty new loci for age at menarche identified by a metaanalysis of genome-wide association studies. Nature Genetics 2010 42 1077-1085. (doi:10.1038/ng.714)
37. Silveira LF, Trarbach EB & Latronico AC. Genetics basis for GnRHdependent pubertal disorders in humans. Molecular and Cellular Endocrinology 2010 324 30-38. (doi:10.1016/j.mce.2010.02.023)